Nexalin Technology, Inc. ( NXL) - Key Metrics
NXL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $0 | -$0.11 | -$0.09 | -$0.09 |
| 2025Q4 | $0.01 | -$0.13 | -$0.06 | -$0.06 |
| 2025Q3 | $0 | -$0.13 | -$0.08 | -$0.08 |
| 2025Q2 | $0 | -$0.10 | -$0.06 | -$0.06 |
| 2025Q1 | $0 | -$0.15 | -$0.11 | -$0.11 |
NXL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 0% | -0.79 |
| 2025Q4 | 0% | -1.07 |
| 2025Q3 | 0% | -1.76 |
| 2025Q2 | 0% | -2.47 |
| 2025Q1 | 0% | -3.25 |
NXL
Price: $0.33
52 week price:
Earnings Per Share: -0.46 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 7.5 million